LexDanaLexDanabeta
Inventor

Daniel V. Paone

Inventor
Lansdale, PA, US

Overview

32→
Patents
2005–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 32 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,287,293Bicyclic heterocyclic compounds as PDE2 inhibitors201910,272,077Piperidinone carboxamide azaindane CGRP receptor antagonists201910,174,037Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors201910,160,7626-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors20189,833,448Piperidinone carboxamide azaindane CGRP receptor antagonists20179,656,990'Cathepsin cysteine protease inhibitors'20179,573,913'Cathepsin cysteine protease inhibitors'20179,499,541'Piperidinone carboxamide indane CGRP receptor antagonists'20169,499,545'Piperidinone carboxamide azaindane CGRP receptor antagonists'20169,458,181'Cathepsin cysteine protease inhibitors'20169,238,647'P2X3 receptor antagonists for treatment of pain'20169,067,941'Fused heterocyclic azaindane carboxamide CGRP receptor antagonists'20158,912,210'Piperidinone carboxamide azaindane CGRP receptor antagonists'20148,895,572'Fused heterocyclic indane carboxamide CGRP receptor antagonists'20148,883,807'Piperidinone carboxamide indane CGRP receptor antagonists'20148,754,096'Piperidinone carboxamide azaindane CGRP receptor antagonists'20148,598,209'P2X3, receptor antagonists for treatment of pain'20138,569,512'P2X3 receptor antagonists for treatment of pain'20138,461,185'P2X3 receptor antagonists for treatment of pain'20138,247,401'P2X3 receptor antagonists for treatment of pain'20128,039,460'CGRP receptor antagonists'20117,994,325'CGRP receptor antagonists'20117,893,052'CGRP receptor antagonists'20117,772,224'CGRP receptor antagonists'20107,745,427'CGRP receptor antagonists'20107,732,438'CGRP receptor antagonists'20107,534,784'CGRP receptor antagonists'20097,491,713'CGRP receptor antagonists'20097,452,903'CGRP receptor antagonists'20087,235,545'CGRP receptor antagonists'20077,205,292'CGRP receptor antagonists'20076,953,790'CGRP receptor antagonists'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2009Patents assigned to MERCK & CO INC (6)· patent assignee history
2005–2009Based in Blue Bell, PA, US· patent location history
2009–2019Based in Lansdale, PA, US· patent location history
2010–2019Patents assigned to MERCK SHARP & DOHME (25)· patent assignee history
2011–2014Based in West Point, PA, US· patent location history
2012–2019Patents assigned to PAONE DANIEL V (11)· patent assignee history
2012–2016Patents assigned to BURGEY CHRISTOPHER S (7)· patent assignee history
2013–2015Patents assigned to GINNETTI ANTHONY (6)· patent assignee history
2014Based in Horsham, PA, US· patent location history
2019Based in Landsdale, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME252010–2019
PAONE DANIEL Vself112012–2019
BURGEY CHRISTOPHER S72012–2016
GINNETTI ANTHONY62013–2015
MERCK & CO INC62005–2009
Locations
LocationPatentsSpan
Lansdale, Pennsylvania, US232009–2019
Blue Bell, Pennsylvania, US52005–2009
West Point, Pennsylvania, US22011–2014
Landsdale, Pennsylvania, US12019
Horsham, Pennsylvania, US12014